SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-18-008551
Filing Date
2018-02-14
Accepted
2018-02-14 20:23:59
Documents
1
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 doc1.html 5  
1 FORM 5 doc1.xml 5 4008
  Complete submission text file 0001140361-18-008551.txt   5337
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Issuer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOMARIN PHARMACEUTICAL INC. 105 DIGITAL DRIVE NOVATO CA 94949
Business Address
SPIEGELMAN DANIEL K (Reporting) CIK: 0001238403 (see all company filings)

Type: 5 | Act: 34 | File No.: 000-26727 | Film No.: 18615732